Dual role of parathyroid hormone in endothelial progenitor cells and marrow stromal mesenchymal stem cells

Journal of Cellular Physiology

Volumn 222, Issue 2, 2010, Pages 474-480

  Di Bernardo, Giovanni ^a   Galderisi, Umberto ^a,b   Fiorito, Carmela ^c   Squillaro, Tiziana ^d   Cito, Letizia ^e   Cipollaro, Marilena ^a   Giordano, Antonio ^b,d,e   Napoli, Claudio ^a,b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b TEMPLE UNIVERSITY   (United States)

^c IRCCS MULTIMEDICA   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

^e Centro Ricerche Oncologiche Mercogliano   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PROTEIN P53; RETINOBLASTOMA PROTEIN; 8 OXO 7 HYDRODEOXYGUANOSINE; 8-OXO-7-HYDRODEOXYGUANOSINE; DEOXYGUANOSINE; DRUG DERIVATIVE; MESSENGER RNA; PTH PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL FATE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; BONE MARROW CELL; CELL AGING; CELL CULTURE; CELL DIFFERENTIATION; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; STEM CELL; STROMA CELL; TIME;

APOPTOSIS; BONE MARROW CELLS; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DEOXYGUANOSINE; DNA DAMAGE; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STEM CELLS; PARATHYROID HORMONE; RECEPTORS, PARATHYROID HORMONE; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; STEM CELLS; STROMAL CELLS; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 73349125475     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21976     Document Type: Article

References (37)

1. Ballen KK, Shpall EJ, Avigan D, Yeap BY, Fisher DC, McDermottK, Dey BR, Attar E, McAfee S, Konopleva M, Antin JH, Spitzer TR. 2007. Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Biol Blood Marrow Transplant 13:838-843.
2. Brunner S, Theiss HD, Murr A, Negele T, Franz WM. 2007. Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells. Am J Physiol Endocrinol Metab 293:E1670-E1675.
3. Brunner S, Zaruba MM, Huber B, David R, Vallaster M, Assmann G, Mueller-Hoecker J, Franz WM. 2008. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow. Exp Hematol 36:1157-1166.
4. Campisi J, d'Adda di Fagagna F. 2007. Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol 8:729-740.
5. Galderisi U, Di Bernardo G, Cipollaro M, Peluso G, Cascino A, Cotrufo R, Melone MA. 1999. Differentiation and apoptosis of neuroblastoma cells: Role of N-myc gene product. J Cell Biochem 73:97-105.
6. Galderisi U, Cipollaro M, Giordano A. 2006. The retinoblastoma gene is involved in multiple aspects of stem cell biology. Oncogene 25:5250-5256.
7. Giaccia AJ, Kastan MB. 1998. The complexity of p53 modulation: Emerging patterns from divergent signals. Genes Dev 12:2973-2983.
8. Giordano A, Galderisi U, Marino IR. 2007. From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells. J Cell Physiol 211:27-35.
9. Hirschi KK, Ingram DA, Yoder MC. 2008. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28:1584-1595.
10. Le Blanc K, Pittenger M. 2005. Mesenchymal stem cells: Progress toward promise. Cytotherapy 7:36-45.
11. Li Q, Qiao J, Deng J, Zeng T, Zhou P, Li W. 2009. Safety, tolerability and pharmacokinetic study of recombinant human parathyroid hormone [rhPTH (1-84)] in Chinese healthy volunteers. J Huazhong Univ Sci Technolog Med Sci 29:431-434.
12. Lo Celso C, Fleming HE, Wu JW, Zhao CX, Miake-Lye S, Fujisaki J, Cote D, Rowe DW, Lin CP, Scadden DT. 2009. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457:92-96.
13. Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt FW. 2005. DNA repair, genome stability, and aging. Cell 120:497-512.
14. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K, Okochi H, Okuda A, Matoba R, Sharov AA, Ko MS, Niwa H. 2007. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9:625-635.
15. Matoba R, Niwa H, Masui S, Ohtsuka S, Carter MG, Sharov AA, Ko MS. 2006. Dissecting Oct3/4-regulated gene networks in embryonic stem cells by expression profiling. PLoS ONE 1:e26.
16. Mieno S, Ramlawi B, Boodhwani M, Clements RT, Minamimura K, Maki T, Xu SH, Bianchi C, Li J, Sellke FW. 2006. Role of stromal-derived factor-1alpha in the induction of circulating CD34+ CXCR4+ progenitor cells after cardiac surgery. Circulation 114:I186-I192.
17. Mikkers H, Frisen J. 2005. Deconstructing stemness. EMBO J 24:2715-2719.
18. Muller-Sieburg CE, Deryugina E. 1995. The stromal cells' guide to the stem cell universe. Stem Cells 13:477-486.
19. Napoli C, Balestrieri A, Ignarro LJ. 2007a. Therapeutic approaches in vascular repair induced by adult bone marrow cells and circulating progenitor endothelial cells. Curr Pharm Des 13:3245-3251.
20. Napoli C, Maione C, Schiano C, Fiorito C, Ignarro LJ. 2007b. Bone marrow cell-mediated cardiovascular repair: Potential of combined therapies. Trends Mol Med 13:278-286.
21. Napoli C,William-Ignarro S, Byrns R, Balestrieri ML, Crimi E, Farzati B, Mancini FP, de Nigris F, Matarazzo A, D'Amora M, Abbondanza C, Fiorito C, Giovane A, Florio A, Varricchio E, Palagiano A, Minucci PB, Tecce MF, Giordano A, Pavan A, Ignarro LJ. 2008. Therapeutic targeting of the stem cell niche in experimental hindlimb ischemia. Nat Clin Pract Cardiovasc Med 5:571-579.
22. Oberdoerffer P, Sinclair DA. 2007. The role of nuclear architecture in genomic instability and ageing. Nat Rev Mol Cell Biol 8:692-702.
23. Pagliarulo C, Salvatore P, Napoli C. 2008. Targeting vascular niche by parathyroid hormone. Curr Med Chem 15:2984-2990.
24. Pearson JD. 2009. Endothelial progenitor cells - Hype or hope? J Thromb Haemost 7:255-262.
25. Prockop DJ. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
26. Pusztaszeri MP, Seelentag W, Bosman FT. 2006. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54:385-395.
27. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA. 2002. "Stemness": Transcriptional profiling of embryonic and adult stem cells. Science 298:597-600.
28. Rickard DJ, Wang FL, Rodriguez-Rojas AM, WuZ, Trice WJ, Hoffman SJ, Votta B, Stroup GB, Kumar S, Nuttall ME. 2006. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Bone 39:1361-1372.
29. Sammons J, Ahmed N, El-Sheemy M, Hassan HT. 2004. The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: Effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3). Stem Cells Dev 13:273-280.
30. Svinareva DA, Nifontova IN, Drize NI. 2004. Effect of parathyroid hormone PTH (1-34) on hemopoietic and stromal stem cells. Bull Exp Biol Med 138:571-574.
31. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
32. von Zglinicki T, Burkle A, Kirkwood TB. 2001. Stress, DNA damage and ageing - An integrative approach. Exp Gerontol 36:1049-1062.
33. Wojakowski W,Tendera M, Michalowska A, Majka M, Kucia M, Maslankiewicz K, Wyderka R, Ochala A, Ratajczak MZ. 2004. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110:3213-3220.
34. Wu JY, Scadden DT, Kronenberg HM. 2009. Role of the osteoblast lineage in the bone marrow hematopoietic niches. J Bone Miner Res 24:759-764.
35. Yang C, Frei H, Burt HM, Rossi F. 2009. Effects of continuous and pulsatile PTH treatments on rat bone marrow stromal cells. Biochem Biophys Res Commun 380:791-796.
36. Zaruba MM, Huber BC, Brunner S, Deindl E, David R, Fischer R, Assmann G, Herbach N, Grundmann S, Wanke R, Mueller-Hoecker J, Franz WM. 2008. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival. Cardiovasc Res 77:722-731.
37. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li L. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425:836-841.